More articles from Oncology, Basic Science Track

You have access
In vivo Molecular Imaging and Radionuclide (188Re) Therapy of Cervical Cancer Transfected with a Lentivirus Expressing Sodium Iodide Symporter using human Telomerase Reverse Transcriptase Promoter
Min Zhang, Rui Guo, Shuo Shi and Biao Li

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 252;
You have access
Response and tolerability after a single dose of Lu-177-PSMA-617 in patients with metastatic castration resistant prostate cancer: a multicenter Study
Kambiz Rahbar, Matthias Schmidt, Alexander Heinzel, Elisabeth Eppard, Anna Yordanova, Michael Claesener, Axel Bode and Hojjat Ahmadzadehfar

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 140;
You have access
PSMA radioligand therapy (PRLT) of metastatic castration-resistant prostate cancer: first results using the PSMA Inhibitor 617
Harshad Kulkarni, AVIRAL SINGH, Karin Niepsch, Christiane Schuchardt and Richard Baum

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 139;
You have access
Targeted radionuclide therapy of malignant tumors using [18F] Fluorodeoxyglucose (FDG): A Phase 1 dose escalation clinical trial
Doru Paul, Shankar Vallabhajosula, Ghiuzeli Cristina, Josephine Rini, Ajay Kapur, Maged Ghaly, Eran Ben Levi, Chris Palestro, Lin Wang, Jose Antony, Panagiotis Kamvosoulis, Hani Gaballa, Elizabeth Connelly and Brett Cox

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 247;
You have access
Feasibility of In-111-PSMA-guided surgery for treatment of nodal prostate cancer relapse
Christian Stoykow, Kathrin Schaal, Michael Mix, Mark Bartholomae, Ulrich Wetterauer, Vanessa Drendel, Wolfgang Schultze-Seemann, Cordula Jilg and Philipp Meyer

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 195;
You have access
Correlation of Tumor Heterogeneity Assessed in 68Ga-HBED-CC-PET (PSMA-Ligand) with Clinical Response After 223Ra-Dichloride-Therapy in Patients with Bone Metastases of Prostate Carcinoma
Barbara Kreppel, Hojjat Ahmadzadehfar, Markus Essler, Norbert Zsoter, Laszlo Papp, Florian Gaertner, Ralph Bundschuh and Lena Thomas

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 249;
You have access
²¹³Bi-labeled PSMA-targeting agents for alpha radionuclide therapy of prostate cancer
Kristell Chatalic, Julie Nonnekens, Frank Bruchertseifer, Alfred Morgenstern, Margret Schottelius, Hans Wester, Wytske van Weerden, Otto Boerman, Marion de Jong and Sandra Heskamp

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 137;
You have access
Targeted radioimmunotherapy with B7-H3-specific 212Pb-mAb 376.96 in models of human ovarian cancer.
Benjamin Kasten, Ashwini Katre, Harrison Kim, Rebecca Arend, Jinda Fan, Soldano Ferrone, Kurt Zinn and Donald Buchsbaum

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 55;
You have access
Quantification of Tumor Vascular Permeability by Positron Emission Tomography with [18F]FAl-NEB
Haojun Chen, Xiao Tong, Lixin Lang, Dale Kiesewetter, Hua Wu, Gang Niu and Xiaoyuan Chen

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 87;
You have access
PET Imaging to Determine HGF Levels in Tumors for Enhanced Patient Selection
Eric Price, Kimberly Edwards, Kathryn Carnazza, Sean Carlin, Kuntal Sevak, Yelena Janjigian and Jason Lewis

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 56;

Main menu

User menu

Search

More articles from Oncology, Basic Science Track

Pages